• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: a recombinant humanized IgG1 anti-DLL3 monoclonal antibody conjugated to payload YL0010014, a topoisomerase I inhibitor
Date Designated: 01/19/2025
Orphan Designation: treatment of small cell lung cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Zai Lab (Shanghai) Co., Ltd
4560 Jinke Road, Pudong Building 1, 4/F, Jinchuang Plaza
Shanghai 201210
China

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-